
The First Training Seminar on Psilocybin-Assisted Therapy Comes to Madrid
First training seminar on psilocybin-assisted therapy in Spain. Three days of clinical training in Madrid, November 2026. Organised by Clínica Synaptica.
Find courses, workshops and professional training programs on the therapeutic use of ketamine and psychedelics in mental health.

First training seminar on psilocybin-assisted therapy in Spain. Three days of clinical training in Madrid, November 2026. Organised by Clínica Synaptica.

This years Ketamine-Assisted Psychotherapy training expands theoretical and experiential learning for health professionals. In this blog we go over our Foundations one-day KAP course. Join us to learn more!

This article introduces the speakers for the Ketamine-Assisted Psychotherapy training program taking place in Barcelona in 2025. The program brings together internationally renowned professionals in psychiatry, psychology, neuroscience, and psychedelic therapies. The instructors contribute decades of clinical experience, scientific research, and the development of innovative therapeutic models. Understanding their backgrounds allows us to appreciate the academic, clinical, and humanistic rigor of the training, as well as the diverse approaches that converge in this unique educational offering.

At Clínica Synaptica, psychoeducation is understood as a key therapeutic tool that fosters self-knowledge and autonomy. In this four-session course, psychotherapist Irene Perez introduces participants to the functioning of the nervous system and its impact on daily life. Through body awareness, practical tools, and visual mapping, the course helps identify states of anxiety, shutdown, and regulation, promoting a more respectful and regenerative relationship with the body.

This glossary brings together key concepts from neuroscience, psychology, and psychiatry related to depression, trauma, addiction, and psychedelic-assisted therapies. It clearly defines terms such as amygdala, anhedonia, neuroplasticity, ketamine, BDNF, and treatment-resistant depression, helping readers better understand scientific articles and therapeutic processes. Designed as an accessible reference, it aims to support both patients and professionals seeking a rigorous, evidence-based understanding of contemporary mental health and emerging therapeutic approaches.
We use cookies to improve the user experience. Consent to these technologies allows us to process data such as browsing behavior.